Patients with a history of diabetic retinopathy should be monitored by an ophthalmologist during semaglutide treatment
However, as with other novel obesity drugs, Mazdutide must overcome certain challenges, such as optimizing dose-escalation strategies to reduce dropout rates due to adverse events, and ensuring consistent and sustained efficacy in larger scale clinical studies
In addition, mammography examinations should be scheduled based on patient age, risk factors, and prior mammogram results
LIRA reduced body weight in both groups, but the magnitude of the weight loss was greater in the Gipr hypo-KO cohort (Fig
The buy and pray model
Semaglutide is an FDA-approved medication originally designed for managing diabetes, but it has gained widespread attention for its powerful benefits in supporting weight loss